Triptolide induces apoptosis in endometrial cancer via a p53-independent mitochondrial pathway

Molecular Medicine Reports

Volumn 9, Issue 1, 2014, Pages 39-44

  Wang, Xiao Fei ^a   Zhao, Yi Bing ^b   Wu, Qiang ^b   Sun, Zhi Hua ^b   Li, Hai Jin ^b  

^a NANJING MEDICAL UNIVERSITY   (China)

^b JIANGSU CANCER HOSPITAL   (China)

Author keywords

Bcl 2 family; Caspase; Endometrial cancer; Mitochondrial pathway; P53 pathway; Triptolide

Indexed keywords

AMINO ACID CHLOROMETHYL KETONES; ANTINEOPLASTIC AGENTS, ALKYLATING; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; CASPASE 3; CASPASE 9; CELL LINE, TUMOR; DITERPENES; DOWN-REGULATION; ENDOMETRIAL NEOPLASMS; EPOXY COMPOUNDS; FEMALE; HUMANS; MITOCHONDRIA; PHENANTHRENES; PROTO-ONCOGENE PROTEINS C-BCL-2; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR PROTEIN P53; UP-REGULATION;

EID: 84893857199     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2013.1783     Document Type: Article

References (33)

1. D'Andrilli G, Bovicelli A, Paggi MG and Giordano A: New insights in endometrial carcinogenesis. J Cell Physiol 227: 2842-2846, 2012
2. Amant F, Moerman P, Neven P, Timmerman D, Van Limbergen E and Vergote L: Endometrial cancer. Lancet 366: 491-505, 2005
3. Hogberg T, Signorelli M, de Oliveira CF, et al: Sequential adjuvant chemotherapy and radiotherapy in endometrial cancer-results from two randomised studies. Eur J Cancer 46: 2422-2431, 2010
4. Horan TC, Zompa MA, Kim CTSKK, et al: Description of the cytotoxic effect of a novel drug abietyl-isothiocyanate on endometrial cancer cell lines. Invest New Drug 30: 1460-1470, 2012
5. Chen YW, Lin GJ, Chia WT, Lin CK, Chuang YP and Sytwu HK: Triptolide exerts anti-tumor effect on oral cancer and KB cells in vitro and in vivo. Oral Oncol 45: 562-568, 2009
6. Leuenroth SJ and Crews CM: Triptolide-induced transcriptional arrest is associated with changes in nuclear substructure. Cancer Res 68: 5257-5266, 2008
7. Johnson SM, Wang XF and Evers BM: Triptolide inhibits proliferation and migration of colon cancer cells by inhibition of cell cycle regulators and cytokine receptors. J Surg Res 168: 197-205, 2011
8. Kang DW, Lee JY, Oh DH, et al: Triptolide-induced suppression of phospholipase D expression inhibits proliferation of MDA-MB-231 breast cancer cells. Exp Mol Med 41: 678-685, 2009
9. Li W, Liu Y, Yu Y, et al: MAPKs are not involved in triptolide-induced cell growth inhibition and apoptosis in prostate cancer cell lines with different p53 status. Planta Med 77: 27-31, 2010.
10. Matsui Y, Watanabe J, Ikegawa M, Kamoto T, Ogawa O and Nishiyama H: Cancer-specific enhancement of cisplatin-induced cytotoxicity with triptolide through an interaction of inactivated glycogen synthase kinase-3β with p53. Oncogene 27: 4603-4614, 2008.
11. Meng HT, Zhu L, Ni WM, You LS, Jin J and Qian WB: Triptolide inhibits the proliferation of cells from lymphocytic leukemic cell lines in association with downregulation of NF-κB activity and miR-16-1*. Acta Pharmacol Sin 32: 503-511, 2011.
12. Yu C, Zhi-hua S,Qiang W and Jian Z: Effects of tirptolide on endometrial cancer in human HEC-1B cells. Prog Obstet Gynecol 18: 282-285, 2009.
13. Jian Z, Zhi-hua S, Qiang W and Yu C: Growth inhibition effect of triptolide on human endometrial cancer cells in vivo. Acta Universitatis Medicinalis Nanjing 29: 775-778, 2009.
14. Xiao-hao H, Zhi-hua S and Qiang W: The effect of triptolide on proliferation and apoptosis signal transduction pathway-PI3K/PKB in human endometrial carcinoma cell line. Acta Universitatis Medicinalis Nanjing 30: 910-913, 2010.
15. Baskic D, Popovic S, Ristic P and Arsenijevic N: Analysis of cycloheximide-induced apoptosis in human leukocytes: fluorescence microscopy using annexin V/propidium iodide versus acridin orange/ethidium bromide. Cell Biol Int 30: 924-932, 2006.
16. Tong JS, Zhang QH, Huang X, et al: Icaritin causes sustained ERK1/2 activation and induces apoptosis in human endometrial cancer cells. Plos One 6: e16781, 2011.
17. Wilkins RC, Kutzner BC, Truong M, Sanchez-Dardon J and McLean JRN: Analysis of radiation-induced apoptosis in human lymphocytes: flow cytometry using Annexin V and propidium iodide versus the neutral comet assay. Cytometry 48: 14-19, 2002.
18. Yang JS, Chung JG, Wu PP, et al: Triptolide induces apoptosis in human adrenal cancer NCI-H295 cells through a mitochondrial-dependent pathway. Oncol Rep 25: 551-557, 2011.
19. Cotter TG: Apoptosis and cancer: the genesis of a research field. Nat Rev Cancer 9: 501-507, 2009.
20. Sasi N, Hwang M, Jaboin J, Csiki I and Lu B: Regulated cell death pathways: new twists in modulation of BCL2 family function. Mol Cancer Ther 8: 1421-1429, 2009.
21. Xu B, Guo XX, Mathew S, Armesilla AL, Cassidy J, Darling JL and Wang WG: Triptolide simultaneously induces reactive oxygen species, inhibits NF-κB activity and sensitizes 5-fluorouracil in colorectal cancer cell lines. Cancer Lett 291: 200-208, 2010.
22. Antonsson B: Bax and other pro-apoptotic Bcl-2 family ?killer-proteins? and their victim the mitochondrion. Cell Tissue Res 306: 347-361, 2001.
23. Kuhar M, Sen S and Singh N: Role of mitochondria in quercetin-enhanced chemotherapeutic response in human non-small cell lung carcinoma H-520 cells. Anticancer Res 26: 1297-1303, 2006.
24. Kim MJ, Lee TH, Kim SH,Choi YJ, Heo J and Kim YH: Triptolide inactivates Akt and induces caspase-dependent death in cervical cancer cells via the mitochondrial pathway. Int J Oncol 37: 1177-1185, 2010.
25. Yang M, Huang J, Pan HZ and Jin J: Triptolide overcomes dexamethasone resistance and enhanced PS-341-induced apoptosis via PI3k/Akt/NF-κB pathways in human multiple myeloma cells. Int J Mol Med 22: 489-496, 2008.
26. Cory S and Adams JM: The bcl2 family: regulators of the cellular life-or-death switch. Nat Rev Cancer 2: 647-656, 2002.
27. Phillips PA, Dudeja V, McCarroll JA, et al: Triptolide induces pancreatic cancer cell death via inhibition of heat shock protein 70. Cancer Res 67: 9407-9416, 2007.
28. Zhu W, Hu H, Qiu P and Yan GM: Triptolide induces apoptosis in human anaplastic thyroid carcinoma cells by a p53-independent but NF-κB-related mechanism. Oncol Rep 22: 1397-1401, 2009.
29. Yao JC, Jiang ZZ, Duan WG, et al: Involvement of mitochondrial pathway in triptolide-induced cytotoxicity in human normal liver L-02 cells. Biol Pharm Bull 31: 592-597, 2008.
30. Wan CK, Wang C, Cheung HY, Yang M and Fong WF: Triptolide induces Bcl-2 cleavage and mitochondria dependent apoptosis in p53-deficient HL-60 cells. Cancer Lett 241: 31-41, 2006.
31. Carter BZ, Mak DH, Schober WD, et al: Triptolide sensitizes AML cells to TRAIL-induced apoptosis via decrease of XIAP and p53-mediated increase of DR5. Blood 111: 3742-3750, 2008.
32. Amundson SA, Myers TG and Fornace AJ Jr: Roles for p53 in growth arrest and apoptosis: putting on the brakes after genotoxic stress. Oncogene 17: 3287-3299, 1998.
33. Mano Y, Kikuchi Y, Yamamoto K, et al: Bcl-2 as a predictor of chemosensitivity and prognosis in primary epithelial ovarian cancer. Eur J Cancer 35: 1214-1219, 1999.